StockDuty Jun 25, 2026 08:24 PM ET
CatalystS-1 Filing

📄 CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

📄 CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company focused on immunology, urology, neurology, and orthopedics using adult stem cell treatments and regenerative technologies. The company markets CaverStem and FemCelz disposable kits for treating erectile dysfunction and female sexual dysfunction, respectively, and is developing StemSpine for degenerative disc disease and ImmCelz technology for stroke and other indications. It is seeking to expand commercial sales and advance clinical trials for its pipeline products. Key risk: We have incurred substantial losses and our future profitability is uncertain. Proceeds: Redeem Bridge Notes in the outstanding amount of $5,146,176, Repurchase Series A Preferred Stock from CEO for approximately $195,000, Hire marketing and sales personnel to support CaverStem and FemCelz sales, Conduct a clinical study of 100 patients for StemSpine Regenerative Stem Cell Procedur
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company focused on immunology, urology, neurology, and orthopedics using adult stem cell treatments and regenerative technologies. The company markets CaverStem and FemCelz disposable kits for treating erectile dysfunction and female sexual dysfunction, respectively, and is developing StemSpine for degenerative disc disease and ImmCelz technology for stroke and other indications. It is seeking to expand commercial sales and advance clinical trials for its pipeline products.
Sources